Foamix Pharmaceuticals Ltd. Gross Profit
Foamix Pharmaceuticals Ltd. reported Gross Profit of $135.00 thousand for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. gross profit for the quarter ending 2019-12-31 was $135.00K, a 84.30% decline year-over-year.
- Foamix Pharmaceuticals Ltd. gross profit for the quarter ending 2019-03-31 was $308.00K, a 66.00% decline year-over-year.
- Foamix Pharmaceuticals Ltd. gross profit for the quarter ending 2018-12-31 was $860.00K, a 17.39% decline year-over-year.
- Foamix Pharmaceuticals Ltd. gross profit for the quarter ending 2018-09-30 was $865.00K, a 2.81% decline year-over-year.
- Foamix Pharmaceuticals Ltd. gross profit for fiscal 2019 was $443.00K, a 87.68% decline from fiscal 2018.
- Foamix Pharmaceuticals Ltd. gross profit for fiscal 2018 was $3.60M, a 1.67% decline from fiscal 2017.
- Foamix Pharmaceuticals Ltd. gross profit for fiscal 2017 was $3.66M, a 33.14% decline from fiscal 2016.
- Foamix Pharmaceuticals Ltd. gross profit for fiscal 2016 was $5.47M, a 601.93% increase from fiscal 2015.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2019-12-31 | $135.00K 10-K · filed 2020-03-12 | $443.00K 10-K · filed 2020-03-12 | ||
| 2019-03-31 | $308.00K 10-K · filed 2020-03-12 | $1.17M derived: sum of 2 quarters · filed 2020-03-12 | $2.03M derived: sum of 3 quarters · filed 2020-03-12 | $3.00M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | $860.00K 10-K · filed 2020-03-12 | $1.73M derived: sum of 2 quarters · filed 2020-03-12 | $2.69M derived: sum of 3 quarters · filed 2020-03-12 | $3.60M 10-K · filed 2020-03-12 |
| 2018-09-30 | $865.00K 10-K · filed 2020-03-12 | $1.83M derived: sum of 2 quarters · filed 2020-03-12 | $2.73M 10-Q · filed 2018-11-07 | $3.78M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $964.00K 10-K · filed 2020-03-12 | $1.87M derived: sum of 2 quarters · filed 2020-03-12 | $2.91M derived: sum of 3 quarters · filed 2020-03-12 | $3.80M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $906.00K 10-K · filed 2020-03-12 | $1.95M derived: sum of 2 quarters · filed 2020-03-12 | $2.84M derived: sum of 3 quarters · filed 2020-03-12 | $3.63M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $1.04M 10-K · filed 2019-02-28 | $1.93M derived: sum of 2 quarters · filed 2019-02-28 | $2.73M derived: sum of 3 quarters · filed 2019-02-28 | $3.66M 10-K · filed 2020-03-12 |
| 2017-09-30 | $890.00K 10-K · filed 2019-02-28 | $1.69M derived: sum of 2 quarters · filed 2019-02-28 | $2.62M 10-Q · filed 2018-11-07 | $4.09M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $798.00K 10-K · filed 2019-02-28 | $1.73M 6-K · filed 2017-08-08 | $3.20M derived: sum of 3 quarters · filed 2019-02-28 | $5.74M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $927.00K 10-K · filed 2019-02-28 | $2.40M derived: sum of 2 quarters · filed 2019-02-28 | $4.94M derived: sum of 3 quarters · filed 2019-02-28 | $5.68M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $1.48M 10-K · filed 2018-03-01 | $4.01M derived: sum of 2 quarters · filed 2018-03-01 | $4.75M derived: sum of 3 quarters · filed 2018-03-01 | $5.47M 10-K · filed 2019-02-28 |
| 2016-09-30 | $2.54M 10-K · filed 2018-03-01 | $3.28M derived: sum of 2 quarters · filed 2018-03-01 | $3.99M derived: sum of 3 quarters · filed 2018-03-01 | |
| 2016-06-30 | $740.00K 10-K · filed 2018-03-01 | $1.45M 6-K · filed 2017-08-08 | ||
| 2016-03-31 | $714.00K 10-K · filed 2018-03-01 | |||
| 2015-12-31 | $779.00K 10-K · filed 2018-03-01 | |||
| 2015-06-30 | $96.00K 6-K · filed 2016-08-10 | $521.00K 6-K · filed 2016-08-10 | ||
| 2014-12-31 | $4.89M 20-F · filed 2017-02-21 | |||
| 2014-06-30 | $461.00K 6-K · filed 2015-10-19 | $1.71M 6-K · filed 2015-10-19 | ||
| 2013-12-31 | $951.00K 20-F · filed 2016-03-02 | |||
| 2012-12-31 | $595.00K 20-F · filed 2015-03-17 |